AstraZeneca’s Trixeo has been approved in the EU as a [...]

Qureight has raised $20 million in a Series B financing [...]

Qureight has raised $20 million in a Series B financing [...]

Glasgow medical technology company Nebu~Flow has secured a £2 million [...]

Full results from the Phase 3 KALOS and LOGOS trials [...]

Phase 3 data for GSK’s depemokimab appear to support the [...]

electronRx will launch its pDx app at the HLTH 2025 [...]

Ethris has dosed the first patient in a Phase 2a [...]